Podowart is a topical medication formulated to treat genital warts by targeting the viral particles of human papillomavirus. Its active ingredient works by inhibiting viral dna replication and promoting the shedding of infected epidermal cells. The drug penetrates the skin layer where the warts are present and interferes with the metabolic pathways essential for viral growth. As a result the visible lesions gradually diminish and the immune response is stimulated to clear residual infection. Clinically the treatment is applied directly to the affected area and the pharmacological effect is localized to minimize systemic exposure. The mechanism involves the conversion of interferon-alpha into its active form which enhances antiviral activity against the wart-causing virus. This coordinated action reduces lesion size and supports clearance without requiring invasive procedures.

Podowart is a topical medication formulated for dermatological use. It is primarily employed to treat viral skin infections such as warts and molluscum contagiosum. The active ingredient in Podowart is podophyllotoxin, a compound derived from the plant podophyllum. Podophyllotoxin works by inhibiting the synthesis of dna and disrupting the mitotic activity of rapidly dividing cells. This interference with cell proliferation leads to the regression of wart tissue and clearance of infected keratinocytes. Clinically the drug is applied directly to the affected area where it penetrates the superficial epidermis and exerts its antiviral effect locally. Its minimal systemic absorption contributes to a favorable therapeutic profile with limited exposure to surrounding healthy skin.

Podowart may cause mild skin irritation at the application site. It can lead to a burning sensation that lasts for a short time. Some users report localized itching or itchiness. Redness or erythema may appear around the treated area. Swelling or mild edema can occur as an inflammatory response. Peeling or dryness of the skin may develop after repeated use. In some cases a tingling feeling is reported during application. Minor discomfort such as soreness may be experienced after treatment.

Podowart may cause localized skin irritation where it is applied. Redness or a mild burning sensation can develop after use. Some people experience itching around the treated area. Swelling or a rash can occasionally appear. Discomfort or tenderness may be felt during the first few days. In rare cases a temporary darkening of the skin can occur. The reaction is usually mild and resolves without treatment. These effects are generally short-lived and not severe.